SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as discussions revolve around the potential of its MASH drug, Pemvidutide, following positive AI-driven analysis of trial data; the community anticipates upcoming 48-week results and a meeting with the FDA. Some are speculating about potential for accelerated approval or a buyout, while others urge caution, pointing to past data and potential dilution risks. Bullish sentiment is fueled by comparisons to other high-performing stocks in the sector.

SAIHEAT Ltd. engages in the operation of cryptocurrency mining. It operates Bitcoin for its own account and provides full suite of services, purchase of mining machines, hosting service, and mining pool. The company was founded by Risheng Li on February 2, 2021, and is headquartered in Singapore.

SAIHEAT Ltd. - Ordinary Shares - Class A

SAIHEAT Ltd

SAIH is trending due to community excitement around its low float and potential for a significant breakout, with many drawing comparisons to other recent parabolic runners. Discussions center on breaking key resistance levels that could trigger a rapid price increase, and its possible connection to AI and data centers.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

XCUR is trending due to positive Phase 2 trial results for its cancer treatment, spurring excitement among investors. The community highlights the massive market potential and the stock's low float, which could lead to a short squeeze. However, some traders are wary of a potential offering this week, given the company's previous cash concerns.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

VOR is trending due to positive sentiment around a recent Phase 3 clinical study, although opinions are split on whether this will be a long-term catalyst or a short-lived pump, as some traders discuss an upcoming share offering and reverse split. Community members are weighing the potential for a short squeeze against concerns of dilution, with some highlighting institutional ownership and potential undervaluation. The stock's volatile price action and high short interest are fueling active discussions.

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

ATMC is trending following shareholder approval of its merger with HCYC Group, driving significant after-hours volume and price action. Community discussions highlight the stock's low float and potential for a short squeeze, with some drawing comparisons to other recent high-flying low float plays. Speculation is rampant regarding potential price targets, with many noting the possible impact of the merger on the company's valuation.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending after being added to the S&P 500, sparking both excitement and skepticism among investors. Bulls anticipate further gains, while bears point to the company's high valuation and an ongoing SEC investigation, suggesting a potential shorting opportunity. Community chatter includes discussions around insider selling and comparisons to past S&P 500 inclusions.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending after reporting a profitable quarter and strong revenue guidance, fueling discussions about its potential as an AI automation leader. The community is analyzing its growth prospects, comparing it to companies like $PLTR, and debating whether it could be a buyout target. Positive sentiment is building around its agentic AI capabilities and potential for significant repricing.

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex is trending due to recent high volatility and a massive intraday surge, sparking discussions about a potential short squeeze and comparisons to other recent high-flying low float stocks. The community is actively debating its potential for a multi-day run and the influence of short sellers, while also awaiting news related to acquisitions. Some traders point to a low float and high borrow rate, suggesting a possible continued upward trajectory.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as excitement builds towards upcoming satellite launches and potential FirstNet integration, with community members discussing the company's prospects in the space-based telecommunications sector. News of SpaceX's potential $800 billion valuation is also fueling conversation, with some suggesting this could positively impact ASTS. Discussions also include analysis of insider selling and short squeeze potential.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Fueled by interim data on their obesity drug, WVE is seeing significant volume and price appreciation. Community chatter highlights potential for a multi-day run, while some traders are wary of an upcoming offering and insider selling. The discussion revolves around the drug's prospects in the competitive weight loss market, comparing it to existing GLP-1 therapies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


gambaidoithuongko

Game Bài Đổi Thưởng